CYTK icon

Cytokinetics
CYTK

Overview Fund Activity

261 hedge funds and large institutions have $4.05B invested in Cytokinetics in 2022 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 103 increasing their positions, 74 reducing their positions, and 18 closing their positions.

Holders
261
Holders Change
+22
Holders Change %
+9.21%
% of All Funds
4.41%
Holding in Top 10
12
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+50%
% of All Funds
0.2%
New
45
Increased
103
Reduced
74
Closed
18
Calls
$33.9M
Puts
$5.95M
Net Calls
+$27.9M
Net Calls Change
+$20.6M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$182M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$152M
3
Lazard Asset Management
3
Lazard Asset Management
New York
$66.8M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$53.2M
5
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$117M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$771K
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$23.2M
3
WA
3
Wasatch Advisors
Utah
$18.7M
4
HM
4
HealthCor Management
New York
$19.1M
5
FCM
5
Frontier Capital Management
Massachusetts
$2.23M
Name Holding Trade Value Shares
Change 		Shares
Change %
Norges Bank
26
Norges Bank
Norway
$29.6M +$6.14M +156,355 +26%
Principal Financial Group
27
Principal Financial Group
Iowa
$26.5M +$594K +15,120 +2%
BNP Paribas Asset Management
28
BNP Paribas Asset Management
France
$25.7M -$5.49M -139,643 -18%
GPP
29
Great Point Partners
Connecticut
$24M -$1.57M -40,000 -6%
Charles Schwab
30
Charles Schwab
California
$23.8M +$256K +6,503 +1%
Assenagon Asset Management
31
Assenagon Asset Management
Luxembourg
$23.2M -$35.4M -900,678 -60%
Ameriprise
32
Ameriprise
Minnesota
$22.1M +$93.2K +2,372 +0.4%
Invesco
33
Invesco
Georgia
$21.5M +$5.85M +148,950 +37%
IHAM
34
Integral Health Asset Management
New York
$20.6M +$2.16M +55,000 +12%
CS
35
Candriam SCA
Luxembourg
$20.4M -$4.7M -119,752 -19%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$19.6M +$1.39M +35,256 +8%
HM
37
HealthCor Management
New York
$19.1M -$25.5M -649,510 -57%
WA
38
Wasatch Advisors
Utah
$18.7M -$26.9M -685,320 -59%
Goldman Sachs
39
Goldman Sachs
New York
$18.5M -$7.49M -190,693 -29%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$18.2M -$4.51M -114,900 -20%
American Century Companies
41
American Century Companies
Missouri
$17.3M +$1.18M +29,989 +7%
EAM
42
Eagle Asset Management
Florida
$17M +$7.74M +196,878 +84%
FC
43
Finepoint Capital
Massachusetts
$16.5M +$16.5M +419,433 New
CAM
44
Cormorant Asset Management
Massachusetts
$15.7M – – –
RSCM
45
Rock Springs Capital Management
Maryland
$15.7M +$15.7M +400,000 New
Nuveen Asset Management
46
Nuveen Asset Management
Illinois
$14.2M +$4.02M +102,426 +40%
BCPEMI
47
Bain Capital Public Equity Management II
Massachusetts
$13.4M -$2.79M -70,929 -17%
LCG
48
Lisanti Capital Growth
New York
$13.1M +$2.69M +68,574 +26%
Barclays
49
Barclays
United Kingdom
$12.9M +$9.71M +247,104 +304%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$12.7M +$4.65M +118,403 +57%
1
2
3 4 5